STAA · Staar Surgical Co

Represents the vesting of restricted stock units ("RSUs") granted to the Reporting Person on February 2, 2026, in connection with his appointment as Interim Co-Chief Executive Officer of the Issuer on such date. These RSUs vested on July 31, 2026. The RSUs convert into common stock on a one-for-one basis.

Represents the vesting of restricted stock units ("RSUs") granted to the Reporting Person on February 2, 2026, in connection with his appointment as Interim Co-Chief Executive Officer of the Issuer on such date. These RSUs vested on July 31, 2026. The RSUs convert into common stock on a one-for-one basis.

Due to clerical errors, the Reporting Person's prior Form 4 filed with the Securities and Exchange Commission on May 19, 2026, incorrectly reported this value as 83,112 when the Reporting Person beneficially owned 76,345 shares. The values have been corrected herein.

Represents the vesting of RSUs granted to the Reporting Person on February 2, 2026, in connection with the Reporting Person's appointment as Interim Co-Chief Executive Officer of the Issuer on such date. The RSUs vested on July 31, 2026. The RSUs convert into common stock on a one-for-one basis.

Represents the vesting of RSUs granted to the Reporting Person on February 2, 2026, in connection with the Reporting Person's appointment as Interim Co-Chief Executive Officer of the Issuer on such date. The RSUs vested on July 31, 2026. The RSUs convert into common stock on a one-for-one basis.

Represents the vesting of restricted stock units ("RSUs") granted to the Reporting Person on June 25, 2025, in connection with her appointment as Chief Financial Officer of the Issuer on such date. These RSUs vest as to 1/3 of the shares subject to the award on each of June 25, 2026, 2027 and 2028. The RSUs convert into common stock on a one-for-one basis.

Represents the vesting of restricted stock units ("RSUs") granted to the Reporting Person on June 25, 2025, in connection with her appointment as Chief Financial Officer of the Issuer on such date. These RSUs vest as to 1/3 of the shares subject to the award on each of June 25, 2026, 2027 and 2028. The RSUs convert into common stock on a one-for-one basis.

Reflects restricted stock units and options to purchase common stock granted to the Reporting Person on June 18, 2026, pursuant to the Issuer's annual non-employee director equity compensation program for the 2026-2027 term. These equity awards vest in full on the earlier of June 18, 2027 or the Issuer's 2027 Annual Meeting of Shareholders.

Reflects restricted stock units granted to the Reporting Person on June 18, 2025, pursuant to the Issuer's annual non-employee director equity compensation program for the 2025-2026 term, which vested on June 18, 2026.

These options were granted to the Reporting Person by the Issuer on June 18, 2026 as director compensation pursuant to the Issuer's Amended and Restated Omnibus Equity Incentive Plan, as amended.

These options will vest and become exercisable on the earlier of: (a) June 18, 2027 and (b) the date of STAAR Surgical Company's (the "Issuer") next annual meeting of shareholders after the grant date, subject, in each case, to Richard T. LeBuhn's (the "Reporting Person") continuous service with the Issuer.

Award of stock options granted to the Reporting Person on June 18, 2026. These stock options will vest in full on the earlier of June 18, 2027 or the Issuer's 2026 annual meeting of shareholders.

Reflects restricted stock units and options to purchase common stock granted to the Reporting Person on June 18, 2026, pursuant to the Issuer's annual non-employee director equity compensation program for the 2026-2027 term. These equity awards vest in full on the earlier of June 18, 2027 or the Issuer's 2027 Annual Meeting of Shareholders.

Reflects restricted stock units and options to purchase common stock granted to the Reporting Person on June 18, 2026, pursuant to the Issuer's annual non-employee director equity compensation program for the 2026-2027 term. These equity awards vest in full on the earlier of June 18, 2027 or the Issuer's 2027 Annual Meeting of Shareholders.

Reflects restricted stock units granted to the Reporting Person on June 18, 2025, pursuant to the Issuer's annual non-employee director equity compensation program for the 2025-2026 term, which vested on June 18, 2026.

Reflects restricted stock units granted to the Reporting Person on June 18, 2026, pursuant to the Issuer's annual non-employee director equity compensation program for the 2026-2027 term. These equity awards vest in full on the earlier of June 18, 2027 or the Issuer's 2027 Annual Meeting of Shareholders.

Reflects restricted stock units granted to the Reporting Person on June 18, 2025, pursuant to the Issuer's annual non-employee director equity compensation program for the 2025-2026 term, which vested on June 18, 2026.

These options were granted to the Reporting Person by the Issuer on June 18, 2026 as director compensation pursuant to the Issuer's Amended and Restated Omnibus Equity Incentive Plan, as amended.

These options will vest and become exercisable on the earlier of: (a) June 18, 2027 and (b) the date of STAAR Surgical Company's (the "Issuer") next annual meeting of shareholders after the grant date, subject, in each case, to Neal C. Bradsher's (the "Reporting Person") continuous service with the Issuer.

Reflects restricted stock units granted to the Reporting Person on June 18, 2026, pursuant to the Issuer's annual non-employee director equity compensation program for the 2026-2027 term. These equity awards vest in full on the earlier of June 18, 2027 or the Issuer's 2027 Annual Meeting of Shareholders.

Reflects restricted stock units granted to the Reporting Person on June 18, 2025, pursuant to the Issuer's annual non-employee director equity compensation program for the 2025-2026 term, which vested on June 18, 2026.

Reflects restricted stock units granted to the Reporting Person on June 18, 2025, pursuant to the Issuer's annual non-employee director equity compensation program for the 2025-2026 term, which vested on June 18, 2026.

Reflects restricted stock units granted to the Reporting Person on June 18, 2025, pursuant to the Issuer's annual non-employee director equity compensation program for the 2025-2026 term, which vested on June 18, 2026.

Reflects restricted stock units and options to purchase common stock granted to the Reporting Person on June 18, 2026, pursuant to the Issuer's annual non-employee director equity compensation program for the 2026-2027 term. These equity awards vest in full on the earlier of June 18, 2027 or the Issuer's 2027 Annual Meeting of Shareholders.

The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $28.215 to $28.35, inclusive.

Represents the settlement of the first tranche of performance stock units awarded to the Reporting Person in connection with her new hire grant under the 2025 PSU Program. The number of shares earned was determined upon certification by the Compensation Committee based on achievement of applicable performance goals. The original grant was exempt pursuant to Rule 16b-3(d) and was not previously reported.

On May 15, 2026, the second tranche of 7,331 PSUs awarded to the Reporting Person under the 2025 PSU Program in connection with his annual equity grant vested, of which 3,730 shares were withheld to satisfy taxes.

On May 15, 2026, the second tranche of 5,499 PSUs awarded to the Reporting Person under the 2025 PSU Program in connection with her annual equity grant vested, of which 2,431 shares were withheld to satisfy taxes.

Represents the settlement of the second tranche of performance stock units awarded under the 2025 PSU Program to the Reporting Person in connection with her promtion to Chief Development Officer. The number of shares earned was determined upon certification by the Compensation Committee based on achievement of applicable performance goals. The original grant was exempt pursuant to Rule 16b-3(d) and was not previously reported.

On May 15, 2026, the second tranche of 3,666 PSUs awarded to the Reporting Person under the 2025 PSU Program in connection with his expanded role as President & Chief Operating Officer vested, of which 1,865 shares were withheld to satisfy taxes.

On May 15, 2026, the second tranche of 5,233 PSUs awarded to the Reporting Person under the 2025 PSU Program in connection with her new hire grant vested, of which 1,877 shares were withheld to satisfy taxes.

On May 15, 2026, the second tranche of 1,100 PSUs awarded to the Reporting Person under the 2025 PSU Program in connection with her promtion to Chief Development Officer vested, of which 599 shares were withheld to satisfy taxes.

On May 15, 2026, the first tranche of 10,466 performance stock units ("PSUs") awarded to the Reporting Person under the Issuer's 2025 Performance Stock Unit Award Program ("2025 PSU Program") in connection with her new hire grant vested, of which 3,755 shares were withheld to satisfy taxes .

Represents the settlement of the first tranche of performance stock units awarded to the Reporting Person in connection with his annual equity grant under the 2025 PSU Program. The number of shares earned was determined upon certification by the Compensation Committee based on achievement of applicable performance goals. The original grant was exempt pursuant to Rule 16b-3(d) and was not previously reported.

Represents the settlement of the second tranche of performance stock units awarded to the Reporting Person in connection with her new hire grant under the 2025 PSU Program. The number of shares earned was determined upon certification by the Compensation Committee based on achievement of applicable performance goals. The original grant was exempt pursuant to Rule 16b-3(d) and was not previously reported.

On May 15, 2026, the first tranche of 2,199 PSUs awarded to the Reporting Person under the 2025 PSU Program in connection with her promtion to Chief Development Officer vested, of which 1,118 shares were withheld to satisfy taxes.

On May 15, 2026, the first tranche of 14,662 performance stock units ("PSUs") awarded to the Reporting Person under the Issuer's 2025 Performance Stock Unit Award Program ("2025 PSU Program") in connection with his annual equity grant vested, of which 7,460 shares were withheld to satisfy taxes .

Represents the settlement of the first tranche of performance stock units awarded under the 2025 PSU Program to the Reporting Person in connection with his expanded role as President & Chief Operating Officer. The number of shares earned was determined upon certification by the Compensation Committee based on achievement of applicable performance goals. The original grant was exempt pursuant to Rule 16b-3(d) and was not previously reported.

Represents the settlement of the first tranche of performance stock units awarded under the 2025 PSU Program to the Reporting Person in connection with her promtion to Chief Development Officer. The number of shares earned was determined upon certification by the Compensation Committee based on achievement of applicable performance goals. The original grant was exempt pursuant to Rule 16b-3(d) and was not previously reported.

Represents the settlement of the second tranche of performance stock units awarded to the Reporting Person in connection with his annual equity grant under the 2025 PSU Program. The number of shares earned was determined upon certification by the Compensation Committee based on achievement of applicable performance goals. The original grant was exempt pursuant to Rule 16b-3(d) and was not previously reported.

Represents the settlement of the first tranche of performance stock units awarded to the Reporting Person in connection with her annual equity grant under the 2025 PSU Program. The number of shares earned was determined upon certification by the Compensation Committee based on achievement of applicable performance goals. The original grant was exempt pursuant to Rule 16b-3(d) and was not previously reported.

On May 15, 2026, the first tranche of 10,997 performance stock units ("PSUs") awarded to the Reporting Person under the Issuer's 2025 Performance Stock Unit Award Program ("2025 PSU Program") in connection with her annual equity grant vested, of which 5,595 shares were withheld to satisfy taxes .

On May 15, 2026, the first tranche of 7,331 PSUs awarded to the Reporting Person under the 2025 PSU Program in connection with his expanded role as President & Chief Operating Officer vested, of which 3,730 shares were withheld to satisfy taxes.